NCT03174548View on ClinicalTrials.gov

A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

September 15, 2017

Study Completion Date

September 15, 2017

Conditions
Diabetes Mellitus
Interventions
DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: solution~Route of administration: oral"

Trial Locations (1)

LS2 9LH

Investigational Site Number 826001, Leeds

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT03174548 - A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects | Biotech Hunter | Biotech Hunter